Literature DB >> 7865710

Jejunal release of prostaglandin E2 in Crohn's disease: relation to disease activity and first-degree relatives.

O Ahrenstedt1, R Hällgren, L Knutson.   

Abstract

Patients with Crohn's disease of the distal ileum show increased permeability to hyaluronan and increased release of histamine and complement components in uninvolved parts of the proximal jejunum. These abnormalities are related to disease activity, and are not found in first-degree relatives. Increased synthesis of prostaglandins has been observed in inflamed areas of the intestine in active Crohn's disease. Our purpose was to measure luminal prostaglandin release in patients with active and inactive Crohn's disease and their first-degree relatives. Twenty-four patients with Crohn's disease of the distal ileum (10 in remission and 12 with inflammatory activity) and 17 of their first-degree relatives were included and compared with healthy control subjects (n = 39). Ten centimetres of the proximal jejunum was isolated between balloons as described previously and perfused with a balanced electrolyte glucose-containing solution. Luminal concentrations of PGE2 and albumin were measured and their luminal release was calculated. Luminal release of PGE2 was significantly higher in patients with Crohn's disease than in control subjects [69.7 +/- 11.5 and 34.0 +/- 4.7 pg/cm per h (3.7 +/- 0.6 and 1.8 +/- 0.3 ng/L), respectively, P < 0.01]. The PGE2 levels, however, were not positively correlated to disease activity. Furthermore, there was a modest, but significant increase in luminal PGE2 in first-degree relatives [53.6 +/- 7.0 pg/cm per h (2.9 +/- 0.4 ng/L), P < 0.05]. These changes were not accompanied by significant changes in luminal permeation of albumin.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7865710     DOI: 10.1111/j.1440-1746.1994.tb01557.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  13 in total

1.  Elevated basal intestinal mucosal cytokine levels in asymptomatic first-degree relatives of patients with Crohn's disease.

Authors:  Anant VK Indaram; Santa Nandi; Sam Weissman; Sing Lam; Beverly Bailey; Meyer Blumstein; Ronald Greenberg; Simmy Bank
Journal:  World J Gastroenterol       Date:  2000-02       Impact factor: 5.742

Review 2.  Prostaglandin E2 receptor distribution and function in the gastrointestinal tract.

Authors:  I Dey; M Lejeune; K Chadee
Journal:  Br J Pharmacol       Date:  2006-10-02       Impact factor: 8.739

3.  Prostaglandin E2 produced by Entamoeba histolytica signals via EP4 receptor and alters claudin-4 to increase ion permeability of tight junctions.

Authors:  Manigandan Lejeune; France Moreau; Kris Chadee
Journal:  Am J Pathol       Date:  2011-05-31       Impact factor: 4.307

4.  Protease-activated receptor-2 activation enhances epithelial wound healing via epidermal growth factor receptor.

Authors:  Mahesha Bandara; Wallace K MacNaughton
Journal:  Tissue Barriers       Date:  2021-09-11

5.  Prostaglandin E(2) couples through EP(4) prostanoid receptors to induce IL-8 production in human colonic epithelial cell lines.

Authors:  I Dey; M A Giembycz; K Chadee
Journal:  Br J Pharmacol       Date:  2009-01-23       Impact factor: 8.739

6.  The role of prostaglandin E2 (PGE 2) in toll-like receptor 4 (TLR4)-mediated colitis-associated neoplasia.

Authors:  Yasmin Hernandez; John Sotolongo; Keith Breglio; Daisy Conduah; Anli Chen; Ruliang Xu; David Hsu; Ryan Ungaro; Lory A Hayes; Cristhine Pastorini; Maria T Abreu; Masayuki Fukata
Journal:  BMC Gastroenterol       Date:  2010-07-16       Impact factor: 3.067

7.  A subgroup of first-degree relatives of Crohn's disease patients shows a profile of inflammatory markers in the blood which is more typical of Crohn's disease patients than of normal individuals.

Authors:  Broide Efrat; Goren Iris; Hongbin Wang; Scapa Eitan; Keisari Yona
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

8.  Loss of EP2 receptor subtype in colonic cells compromise epithelial barrier integrity by altering claudin-4.

Authors:  Manigandan Lejeune; France Moreau; Kris Chadee
Journal:  PLoS One       Date:  2014-11-14       Impact factor: 3.240

9.  Antagonizing arachidonic acid-derived eicosanoids reduces inflammatory Th17 and Th1 cell-mediated inflammation and colitis severity.

Authors:  Jennifer M Monk; Harmony F Turk; Yang-Yi Fan; Evelyn Callaway; Brad Weeks; Peiying Yang; David N McMurray; Robert S Chapkin
Journal:  Mediators Inflamm       Date:  2014-07-17       Impact factor: 4.711

10.  PGE2 is a direct and robust mediator of anion/fluid secretion by human intestinal epithelial cells.

Authors:  Satoru Fujii; Kohei Suzuki; Ami Kawamoto; Fumiaki Ishibashi; Toru Nakata; Tatsuro Murano; Go Ito; Hiromichi Shimizu; Tomohiro Mizutani; Shigeru Oshima; Kiichiro Tsuchiya; Tetsuya Nakamura; Akihiro Araki; Kazuo Ohtsuka; Ryuichi Okamoto; Mamoru Watanabe
Journal:  Sci Rep       Date:  2016-11-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.